Hawkins, Inc. (Nasdaq: HWKN) today announced results for the three
and six months ended September 27, 2020, its second quarter of
fiscal 2021. Highlights include:
- Tenth consecutive quarter of year-over-year operating income
growth, with record quarterly operating income of $16.6 million, an
increase of 26% over the $13.2 million recorded in the second
quarter of the prior year.
- Record second quarter sales of $147.8 million, an increase of
6% from the second quarter of fiscal 2020, with growth of 42% in
our Health and Nutrition segment.
- Record second quarter diluted earnings per share (EPS) of
$1.15, which was $0.28, or 32%, higher than EPS of $0.87 in the
second quarter of fiscal 2020.
- Record first half diluted EPS of $2.25, a 26% increase over the
first half fiscal 2020 EPS of $1.79
- Record quarterly operating cash flow of $18.6 million in the
second quarter.
- Net debt of $72.8 million and a leverage ratio of 1.0x, after
the purchase of American Development Corporation of Tennessee, Inc
("ADC").
“We were very pleased with this quarter’s continued
profitability growth, including a 32% increase in net income this
quarter,” said Patrick H. Hawkins, Chief Executive Officer and
President. “As we expected, we continue to operate and execute on
our business strategy through this pandemic, with our business
segment operating results continuing to be mixed into the second
quarter due to the varying impacts of COVID-19. In particular, our
Health and Nutrition segment reported revenue growth of 42% over
the same period last year, with operating income increasing nearly
fivefold over last year largely due to increased demand for health
and immunity products. Our Water Treatment segment results
strengthened in the second quarter compared to the first quarter
and compared to the second quarter in the prior year, as the
negative impact of COVID-related pool closures lessened and we saw
increased demand for many of our products. Our Industrial segment
reported lower results due to reduced demand for certain products.
Looking forward, we do expect continued year-over-year improvement
in the second half of the fiscal year as our specialty
and manufactured products continue to grow.”
Mr. Hawkins continued, “We are also delighted that, due to
record operating cash flow in the second quarter, we were able to
fund the acquisition of ADC with net borrowings in the quarter
increasing only $10 million. The integration of ADC is going well,
and the operating results are already accretive to our bottom
line.”
Second Quarter Financial
Highlights:
Sales were $147.8 million for the second quarter of fiscal 2021,
an increase of 6%, from sales of $140.0 million for the same period
of the prior year. Industrial segment sales decreased $6.9 million,
or 10%, to $61.2 million for the current quarter, as compared to
$68.1 million for the same period of the prior year. The decrease
in sales dollars from the prior year was driven by lower overall
volumes sold. Water Treatment segment sales increased $3.6 million,
or 8%, to $49.5 million for the current quarter, as compared to
$45.9 million for the same period of the prior year. The increase
in sales dollars from the prior year was largely attributable to
the added sales from the acquisition of ADC, while our legacy
business also increased due to increased sales of our manufactured,
blended and repackaged products. Sales for our Health and Nutrition
segment increased $11.0 million, or 42%, to $37.1 million for the
current quarter, as compared to $26.1 million for the same period
of the prior year. The increase in sales was driven by increased
sales of both our manufactured and specialty distributed products
largely as a result of increased consumer demand for health and
immunity products.
Gross profit increased $4.8 million to $32.8 million, or 22% of
sales, for the current quarter, from $28.0 million, or 20% of
sales, for the same prior year period. During the current quarter,
the LIFO reserve decreased, and gross profits increased, by $0.2
million. In the same quarter a year ago, the LIFO reserve
decreased, and gross profits increased, by $0.3 million. Gross
profit for the Industrial segment decreased $0.3 million to $10.4
million, or 17% of sales, for the current quarter, from $10.7
million, or 16% of sales, for the same period of the prior year.
Total Industrial segment gross profit decreased slightly due to the
overall reduction in sales. Gross profit for the Water Treatment
segment increased $1.8 million to $14.5 million, or 29% of sales,
for the current quarter, from $12.8 million, or 28% of sales, for
the same period of the prior year. Gross profit in our Water
Treatment segment increased as a result of the added gross profit
from the acquisition of ADC as well as increased sales in our
legacy business. Gross profit for our Health and Nutrition segment
increased $3.2 million to $7.8 million, or 21% of sales, for the
current quarter, from $4.6 million, or 18% of sales, for the same
period of the prior year, primarily as a result of higher sales
compared to the prior year.
Company-wide selling, general and administrative expenses were
$16.2 million, or 11% of sales, for the current quarter, compared
to $14.8 million, or 11% of sales, for the same period of the prior
year. Expenses increased in part due to increased variable pay and
the added costs due to the ADC acquisition, including $0.2 million
expense for amortization of intangibles, as well as an unfavorable
adjustment to compensation expense related to our non-qualified
deferred compensation plan, which expense is offset in other
income. As a percentage of sales, SG&A was relatively flat year
over year when adjusted for the expense related to the
non-qualified deferred compensation plan and the amortization of
the intangibles related to ADC.
Our effective income tax rate was 26.4% for the current quarter,
compared to 26.2% in the same period of the prior year. The
effective tax rate is impacted by projected levels of annual
taxable income, permanent items, and state taxes.
Earnings before interest, taxes, depreciation and amortization
("EBITDA"), a non-GAAP financial measure, is an important
performance indicator and a key compliance measure under the terms
of our credit agreement. An explanation of the computation of
EBITDA is presented below. EBITDA for the three months ended
September 27, 2020 was $23.4 million, an increase of $4.2
million, or 22%, from EBITDA of $19.2 million for the same period
of the prior year. The increase was primarily due to improved gross
profit.
About Hawkins, Inc.
Hawkins, Inc. distributes, blends and manufactures chemicals and
other specialty ingredients for its customers in a wide variety of
industries. Headquartered in Roseville, Minnesota, and with 44
facilities in 20 states, the Company creates value for its
customers through superb customer service and support, quality
products and personalized applications.
Reconciliation of Non-GAAP Financial Measures
We report our consolidated financial results in accordance with
U.S. generally accepted accounting principles (GAAP). To assist
investors in understanding our financial performance between
periods, we have provided certain financial measures not computed
according to GAAP, including adjusted EBITDA. This non-GAAP
financial measure is not meant to be considered in isolation or as
a substitute for comparable GAAP measures. The method we use to
produce non-GAAP results is not computed according to GAAP and may
differ from the methods used by other companies.
Management uses this non-GAAP financial measure internally to
understand, manage and evaluate our business and to make operating
decisions. Management believes that this non-GAAP financial measure
reflects an additional way of viewing aspects of our operations
that, when viewed with our GAAP results, provides a more complete
understanding of the factors and trends affecting our financial
condition and results of operations.
We define adjusted EBITDA as GAAP net income adjusted for the
impact of the following: net interest expense resulting from our
net borrowing position; income tax expense; non-cash expenses
including amortization of intangibles, depreciation, goodwill
impairment, and charges for the employee stock purchase plan and
restricted stock grants; and non-recurring items of income or
expense, if applicable.
Adjusted
EBITDA |
Three Months Ended |
|
Six months ended |
(In thousands) |
September 27, 2020 |
|
September 29, 2019 |
|
September 27, 2020 |
|
September 29, 2019 |
Net Income (GAAP) |
$ |
12,190 |
|
|
$ |
9,250 |
|
|
$ |
23,978 |
|
|
$ |
19,057 |
|
Interest expense, net |
339 |
|
|
666 |
|
|
719 |
|
|
1,429 |
|
Income tax expense |
4,374 |
|
|
3,287 |
|
|
8,621 |
|
|
6,795 |
|
Amortization of intangibles |
1,447 |
|
|
1,269 |
|
|
2,715 |
|
|
2,537 |
|
Depreciation expense |
4,134 |
|
|
4,117 |
|
|
8,350 |
|
|
8,202 |
|
Non-cash compensation expense |
686 |
|
|
636 |
|
|
1,386 |
|
|
1,145 |
|
Non-recurring acquisition expenses |
265 |
|
|
— |
|
|
265 |
|
|
— |
|
Adjusted
EBITDA |
$ |
23,435 |
|
|
$ |
19,225 |
|
|
$ |
46,034 |
|
|
$ |
39,165 |
|
HAWKINS,
INC.CONSOLIDATED STATEMENTS OF INCOME
(UNAUDITED)(In thousands, except share and
per-share data)
|
Three Months Ended |
|
Six Months Ended |
|
September 27, 2020 |
|
September 29, 2019 |
|
September 27, 2020 |
|
September 29, 2019 |
Sales |
$ |
147,801 |
|
|
$ |
140,043 |
|
|
$ |
290,973 |
|
|
$ |
287,379 |
|
Cost of sales |
(115,004 |
) |
|
(112,049 |
) |
|
(227,200 |
) |
|
(230,588 |
) |
Gross profit |
32,797 |
|
|
27,994 |
|
|
63,773 |
|
|
56,791 |
|
Selling, general and administrative expenses |
(16,221 |
) |
|
(14,817 |
) |
|
(31,259 |
) |
|
(29,653 |
) |
Operating income |
16,576 |
|
|
13,177 |
|
|
32,514 |
|
|
27,138 |
|
Interest expense, net |
(339 |
) |
|
(666 |
) |
|
(719 |
) |
|
(1,429 |
) |
Other income |
327 |
|
|
26 |
|
|
804 |
|
|
143 |
|
Income before income taxes |
16,564 |
|
|
12,537 |
|
|
32,599 |
|
|
25,852 |
|
Income tax expense |
(4,374 |
) |
|
(3,287 |
) |
|
(8,621 |
) |
|
(6,795 |
) |
Net income |
$ |
12,190 |
|
|
$ |
9,250 |
|
|
$ |
23,978 |
|
|
$ |
19,057 |
|
Weighted average number of shares
outstanding - basic |
10,527,891 |
|
|
10,575,538 |
|
|
10,526,511 |
|
|
10,589,922 |
|
Weighted average number of shares
outstanding - diluted |
10,622,881 |
|
|
10,633,117 |
|
|
10,634,281 |
|
|
10,663,864 |
|
Basic earnings per share |
$ |
1.16 |
|
|
$ |
0.87 |
|
|
$ |
2.28 |
|
|
$ |
1.80 |
|
Diluted earnings per share |
$ |
1.15 |
|
|
$ |
0.87 |
|
|
$ |
2.25 |
|
|
$ |
1.79 |
|
Cash dividends declared per common share |
$ |
0.2325 |
|
|
$ |
0.23 |
|
|
$ |
0.465 |
|
|
$ |
0.46 |
|
Forward-Looking Statements. Various remarks in this press
release constitute forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended. These
statements include those relating to impact and duration of wage
pressures, the levels of investment and the impact of investments
on our business operations and financial condition, the timing of
new Water Treatment branch investments, and the duration and impact
of product shortages. These statements are not historical facts,
but rather are based on our current expectations, estimates and
projections, and our beliefs and assumptions. Forward-looking
statements may be identified by terms, including “anticipate,”
“believe,” “can,” “could,” “expect,” “intend,” “may,” “predict,”
“should,” or “will” or the negative of these terms or other
comparable terms. These statements are not guarantees of future
performance and are subject to certain risks, uncertainties and
other factors, some of which are beyond our control and are
difficult to predict. Actual results may vary materially from those
contained in forward looking statements based on a number of
factors, including, but not limited to, the impact and severity of
the COVID-19 outbreak, changes in the labor markets, our available
cash for investments, our business capital needs, changes in
competition and price pressure, changes in demand and customer
requirements or processes for our products, interruptions in
production resulting from hazards, transportation limitations or
other extraordinary events outside our control that may negatively
impact our business or the supply chains in which we participate,
our ability to locate suitable real estate for new branch
additions, changes in imported products and tariff levels, the
availability of products and the prices at which they are
available, the acceptance of new products by our customers and the
timing of any such acceptance, and changes in product supplies.
Additional information concerning potential factors that could
affect future financial results is included in our Annual Report on
Form 10-K for the fiscal year ended March 29, 2020, as updated from
time to time in amendments and subsequent reports filed with the
SEC. Investors should take such risks into account when making
investment decisions. Shareholders and other readers are cautioned
not to place undue reliance on forward-looking statements, which
reflect our management’s view only as of the date hereof. We do not
undertake any obligation to update any forward-looking
statements.
Contacts: |
Jeffrey P. Oldenkamp |
|
Chief Financial Officer |
|
612/331-6910 |
|
Jeff.Oldenkamp@HawkinsInc.com |
Hawkins (NASDAQ:HWKN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Hawkins (NASDAQ:HWKN)
Historical Stock Chart
From Apr 2023 to Apr 2024